Home > Press > Researcher Bilgicer using nanotechnology to improve cancer treatment
![]()  | 
| Basar Bilgicer, assistant professor of chemical and biomolecular engineering | 
Abstract:
Research directed by Basar Bilgicer, assistant professor of chemical and biomolecular engineering and a member of the Advanced Diagnostics and Therapeutics initiative at the University of Notre Dame, could one day enable clinicians to deliver powerful chemotherapy drugs to tumors without deleterious side effects.
Although chemotherapeutic agents are poisonous to tumors, they also can kill healthy cells, leading to toxic side effects.
Bilgicer's research involves developing drug-loaded nanoparticles to target the tumor tissue, so that the chemotherapeutic agents can be delivered specifically to the tumors rather than healthy tissue.
His studies are based on the fact that nanoparticles accumulated in the tumor tissue, whose leaky blood vessels allowed the nanoparticles to pass out of the capillaries that feed the tumor. While the nanoparticles are small enough to penetrate the tumor tissue, they are too large to pass into other tissues in vital organs such as the kidneys, lungs, liver or spleen. Once the molecule is firmly lodged in the tumor, the higher acidity of the tumor environment causes the release of the chemotherapeutic load, thereby dumping its toxicity fully on cancerous tissues rather than traveling to healthy cells.
Although Bilgicer's studies have primarily been in blood cancers, he notes that the nanoparticles also have application in lung and breast cancers. The nanoparticles will require further development and clinical trials before they are ready for patient care.
Bilgicer will be collaborating with Rudolph Navari, director of Notre Dame's Walter Cancer Institute and assistant dean of the Indiana University School of Medicine South Bend, to study the compound's possible uses in oncology treatment.
####
For more information, please click here
Contacts:
Basar Bilgicer
574-631-1429
Copyright © University of Notre Dame
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
| Related News Press | 
News and information
    Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
    Next-generation quantum communication October 3rd, 2025
    "Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Videos/Movies
    ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
    New X-ray imaging technique to study the transient phases of quantum materials December 29th, 2022
    Solvent study solves solar cell durability puzzle: Rice-led project could make perovskite cells ready for prime time September 23rd, 2022
    Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Possible Futures
    Spinel-type sulfide semiconductors to operate the next-generation LEDs and solar cells For solar-cell absorbers and green-LED source October 3rd, 2025
Academic/Education
    Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
    Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
    New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
    New imaging approach transforms study of bacterial biofilms August 8th, 2025
    Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
    Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
    Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
    Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
    Next-generation quantum communication October 3rd, 2025
    "Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Nanobiotechnology
    New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
    New imaging approach transforms study of bacterial biofilms August 8th, 2025
    Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
    Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
| 
			 | 
	||
| 
			 | 
	||
| The latest news from around the world, FREE | ||
| 
			 | 
	||
| 
			 | 
	||
| Premium Products | ||
| 
			 | 
	||
| 
			Only the news you want to read! 
			 Learn More  | 
		||
| 
			 | 
	||
| 
			Full-service, expert consulting 
			 Learn More  | 
		||
| 
			 | 
	||